PUBLISHER: BCC Research | PRODUCT CODE: 1341911
PUBLISHER: BCC Research | PRODUCT CODE: 1341911
The global next-generation sequencing (NGS) market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a compound annual growth rate (CAGR) of 17.7% for the forecast period of 2023 to 2028.
North American NGS market in drug development is expected to grow from $539.8 million in 2023 to $1.2 billion in 2028 at a CAGR of 18.0% for the forecast period of 2023 to 2028.
Asia-Pacific NGS market in drug development is expected to grow from $311 million in 2023 to $743.6 million in 2028 at a CAGR of 19.0% for the forecast period of 2023 to 2028.
The scope of this report includes NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS in drug development are given for 2020, 2021, 2022, 2023 and 2028.
This report reviews the NGS technologies and explains why NGS is important in drug development. It then discusses some of the significant research initiatives that impact NGS. The main market-driving forces are also discussed.
This report examines the markets by product type, end user and region. This report provides market data and forecasts for NGS by product type, including instruments, consumables and services for drug development.
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the Rest of the World.
BCC Research summarizes the main industry acquisitions and strategic alliances from Jan. 2020, through Dec. 2022, including key alliance trends.